Biomarkers for the prediction of vasospasm and delayed cerebral ischemia in patients with a ruptured cerebral aneurysm could be helpful.
Introduction
Subarachnoid hemorrhage (SAH) is a dramatic event with a rapid rise in intracranial pressure. Severe headache, nausea, vomiting, double vision, and nuchal rigidity, aneurysm and development of SAH is rather high, around 50%. (9) Approximately 10% of patients die before reaching hospital, 25 % die in the first 24 hours, and another 25% die in the first month after rupture, usually due to recurrent bleeding. (10) Risk of recurrent bleeding in the first 24 hours after aneurismal rupture is between 2.6 to 4%. (11, 12) The majority (73%) of recurrent bleeding occurs in the first 3 days after rupture. (13) In addition, patients with SAH can also develop delayed cerebral ischemia. It is explained mainly by the development of cerebral vasospasm. Clinical manifestations of these events are impaired consciousness and focal neurologic deficits.
Literature data about the incidence of cerebral vasospasm in patients with ruptured cerebral aneurysm and SAH vary in the range of 1.5 to 91% which demonstrates the diagnostic difficulties when different methods and different definitions are used. (14, 15) In general the incidence could be considered around 20-30%. (16) An up-to-date uniform method for definition and classification of cerebral vasospasm has not been established yet. (17) Cerebral angiography could be chosen as the gold standard for the recognition of cerebral vasospasm, but it provides insight into spasm of large arteries only and cannot show the state of the microcirculation. An association between diffuse angiographic vasospasm and patient outcome has not been found. (15) Repeated angiography for vasospasm monitoring in patients with SAH is not appropriate. Some authors suggest serial exams using transcranial Doppler to detect development of cerebral vasospasm. (18, 19) However, a higher velocity of blood flow is not always seen in patients with cerebral vasospasm. Surprisingly, reduced blood flow can be found in some patients, compromising the transcranial Doppler as a unique method in diagnosing and monitoring of cerebral vasospasm. (17) Despite its imperfection, clinical assessment is often used as a method for estimation of the presence of cerebral vasospasm. (20) Clinical judgement has been shown to be superior in the prediction of cerebral ischemia and its consequences compared to angiography or transcranial doppler (TCD) defined cerebral vasospasm. (21) Subjectivity and difficulties in the clinical assessment of consciousness in sedate and anesthetized patients, as well as low sensitivity for subtle changes in consciousness remain the main weaknesses of this method. (21, 22) The main goal of surgical intervention is prevention of recurrent bleeding. Cerebral vasospasm is usually not present in the first three days after the aneurismal rupture. It develops typically between the 4 th and 14 th day after rupture. (9) According to some authorities, surgical intervention should not be performed in the presence of vasospasm, instead, it should be either done earlier, in the first three days after the rupture, or it should be delayed for two weeks after the rupture. It could be supposed that cerebral vasospasm is already resolved two weeks after the rupture.
Additional biochemical markers of cerebral vasospasm and cerebral ischemia could be helpful in routine clinical practice. In the case of cerebral vasospasm, hyperventilation during surgical intervention should be avoided. According to some authors, blood oximetry of samples obtained from the jugular bulb during the operation can provide information about the presence of cerebral ischemia. (23) (24) (25) Lower oxygen saturation of hemoglobin is associated with higher oxygen release in ischemic areas of the brain, which are developed by vasospasm.
Lactate is a product of anaerobic metabolism and is a well known marker of tissue ischemia. Measurements of lactate concentrations in the jugular vein and comparison with concentrations in arterial blood could potentially provide an insight into the amount of energy produced in the brain by anaerobic metabolism. (26, 27) Pathogenesis of cerebral vasospasm is not completely clear. It is supposed that degraded products of blood induce vasoconstriction of arteries in the cerebrospinal space.
Endothelin released from the intimal layer of blood vessels is a potent vasoconstrictor.
Several experimental studies as well as some clinical studies demonstrated its potential role in the development of cerebral vasospasm. (28-31) Still, there are several studies which could not confirm this finding. (32) (33) (34) In our study, concentrations of endothelin-1, lactate, and partial pressures of oxygen (PO 2 ) and carbon dioxide (pCO 2 ) were tested in arterial and jugular vein blood as predictors of outcome and potential markers of cerebral vasospasm and ischemia in patients who underwent operation of cerebral aneurysm.
Patients and methods
The study was approved by the Clinical Hospital Centre Zagreb Ethics Committee.
Patients who underwent neurosurgical operation of a cerebral artery aneurysm were considered eligible for enrollment in this prospective study. Inclusion criteria were: inform consent signed by the patient or close relative and availability of the investigator during the operative procedure. The patients were divided into two groups: group 1 with a ruptured cerebral aneurysm and group 2 with a nonruptured cerebral aneurysm. The latter represent the control group.
For preoperative sedation all patients received midazolam intramuscularly. Thiopental was used in a dose of 3-6 mg/kg of body weight and fentanyl in a dose of 0.5-9 ug/kg for induction of anesthesia and intubation. Muscle relaxants, vecuronium or pancuronium, were given at a dose of 0.1 do 0.15 mg/kg and recuronium at a dose of 0.6 do 1.2 mg/kg.
For maintenance of anesthesia, tiopental and fentanyl drip were used. Target systolic blood pressure, till clamping of aneurysm, was 95-100 mmHg.
After clamping of the aneurysm, reasonable triple H therapy (hemodilution, hypertension and hypervolemia) was conducted in all patients. Dosage was individualized during the operation by the attending anesthesiologist and in the intensive care unit after the operation. Target hematocrit was 33-38%, target central venous pressure was 5-12 mmHg, and target systolic blood pressure was 130-200 mmHg.
Continuous intravenous nimodipine was included in the postoperative period if the systolic blood pressure exceeded 140 mmHg, and its dosage was titrated until target systolic blood pressures were reached. Maximal dose of nimodipine was 2 mg/h. Normal saline infusion was used to keep patients optimally hydrated or mildly hyperhydrated.
Simultaneous blood samples for laboratory analysis were obtained from the radial artery and from the jugular vein bulbus in all patients. Samples were taken: after induction of anesthesia, before the operation, after opening the dura mater, 5 minutes after clamping of the aneurismal neck, 30 minutes after aneurismal clamping, after postoperative arrival in the intensive care unit, after awakening, after extubation and on the day after the operation. Blood gases and lactate concentrations were measured in all samples.
Endothelin-1 concentrations were measured in samples obtained before the beginning of the surgical procedure, during the operation (30 minutes after clamping of the aneurismal neck) and the next morning after the operation.
Neurologic state was followed and recorded using the Hunt Hess scale. State of consciousness was assessed using the Glasgow Coma Scale (GCS), (35) (36) (37) before induction of anesthesia, every hour during the first 24 hours after the operation, and daily in the later postoperative period. Evaluation of motoric deficit was performed before the operation, after recovery from general anesthesia and 6 months after the operation.
Glasgow Coma Scale of 14 or lower, as well as worsening of motoric deficit, were the main criteria for diagnosis of delayed cerebral ischemia and cerebral vasospasm, after other possible causes were excluded. (38) Investigators who evaluated state of consciousness and motoric deficit were "blind" to the laboratory results.
A modified Marbach-Weil method ("Dade Behring, Dimension Clinical Chemistry System") was used for the measurements of blood lactate concentrations using "Lactic Acid Flex" reagents. (39, 40) Endothelin-1 concentrations were measured by ELISA method ("Biomedical Assays"). PCO 2 in blood was measured by potentiometry and PO 2 in blood by amperometry (GEM Premier 3000).
Functional outcome was measured by modified Rankin scale 6 months after the operation.
When Rankin score was 3 or higher, the outcome was classified as poor. (41) (42) (43) Statistical analysis was performed using MedCalc Software version 12.1.3. (Mariakerke, Belgium).
Numerical variables were tested for the normality of distribution using KolmogorovSmirnov test and were presented as mean ± standard deviation or median (interquartile range) as appropriate. T test was used to compare normally distributed variables, and ANOVA was used to explore the difference among more than two subgroups (Hochberg's test for post hoc analysis). Kruskal-Wallis test was used to explore the difference between more than two variables that were not distributed normally. Nonparametric MannWhitney U-test was used to compare the difference between two subgroups with no normally distributed variables. To compare the difference in proportions, Pearson's χ2 and χ2 for post hoc analysis were used. Fisher's test was used in case of small sample size.
To determine the correlation between two continuous variables Spearman's rho test was used. P value <0.05 was considered significant.
Results
Over a period of two years, 144 patients underwent surgery for a cerebral artery aneurysm.
Forty-one consecutive patients from this group were enrolled in the study. The selection depended on the availability of the investigator during the surgical procedure and patients' consent to be included in the study.
There were 30 females (73.2%) and 11 males (26.8%). By binominal test, females were significantly more common (P=0.003).
In 31 patients (75.6 %), the aneurysm was present on one of the cerebral arteries, whereas in 10 (24.4%) patients, aneurysms were found on more than one artery.
In 23 (56.1%) patients, the operation was performed after aneurismal rupture and development of SAH, while in 18 (43.9%) patients a nonruptured aneurysm was discovered coincidentally, and the operative procedure was elective.
There was no difference between these two groups according to age, gender, and mean arterial pressure before, during and after the operation (table 1) .
Patients with a nonruptured aneurysm awakened significantly earlier after the operation and were extubated earlier than those operated on after aneurysm rupture and SAH development. The amount of thiopental administered during the operation was somewhat larger in the group with SAH but the statistical significance was borderline. Frequency of neurologic deficits did not differ between groups. There was no difference in Glasgow outcome scale (GOS) and Rankin outcome scale between these two groups in the postoperative period, as well as 6 months after the operation.
Analysis of blood samples obtained before aneurysm clamping, 5 and 30 minutes after clamping, at arrival to the intensive care unit (ICU) after the operation, at the moment of awakening, at the moment of extubation and the next day after the operation, did not show significant differences in blood gases, lactate and endothelin-1 values between the two groups.There was some statistically significant, but clinically irrelevant, difference in the results of blood gas analysis. Comparison of the groups with favorable and unfavorable outcome for arteriovenous difference in lactate concentration on the day after the operation, showed a higher difference in the group with a unfavorable outcome (table 2) .
There were also statistically significant differences in pCO 2 during the operation and immediately after the operation showing lower pCO 2 in the group with an unfavorable neurologic outcome. Other measured parameters did not differ significantly between these two groups.
Several correlations were found using Spearman rho statistical test. There was a clear correlation between venoarterial difference of lactate concentrations in samples obtained 30 minutes after aneurismal clamping and initial GCS and Hunt Hess score. The same correlation was found with almost all GCS scores after general anesthesia, assessed every hour after the operation (table 3) .Thus, such a correlation could not be found for absolute lactate concentrations from arterial and venous blood samples. This finding point out that there is higher lactate production, during the operation, in brains of patients with a lower GCS.
Higher venoarterial difference in lactate concentrations before induction of anesthesia was associated with lower initial GCS, as well as with lower GCS 21 hours and 2 days after operation.
Significant correlation was found between the following scores and pCO 2 : Hunt Hess before surgery, GCS score before and after the operation and pCO 2 in venous and arterial blood samples obtained at the time of extubation and on the morning after the operation (table 3) . 2 in venous and arterial blood after the operation, at the time when patients were transferred to the ICU (r S 0,445, P=0.04).
There was positive correlation between endotelin-1 concentrations in the jugular vein before the operation and hours until recovery of consciousness from general anesthesia.
Patients with higher endotelin-1 needed more time to wake spontaneously.
Positive correlation was also found between the time period in hours from rupture to operation and endothelin-1 concentrations in the jugular vein before patients were operated.
The population of patients operated on 3 or less days after aneurismal rupture had significantly higher endothelin-1 concentrations in the jugular vein before the operation compared to those operated later (r S =0,516; P=0,034). This however was not shown if the population with SAH was analysed.
There is a correlation between lactate concentrations in the vein and artery and the time of extubation (arterial lactate r S =0,346; P=0,029, venous lactate r S =0,490; P=0,001).
No correlation between GOS and Rankin score and some of measured biochemical parameters was found.
Discussion
The Eetiology of cerebral ischemia in cerebral aneurysm rupture is multifactorial. Arterial vasospasm is supposed to play the main role, still, impairment of autoregulation of cerebral blood flow, presence or absence of collateral circulation, possible spasm of small vessels, platelets aggregation, as well as negative side effects of angiography and the surgical procedure may also have a significant role. (21, (44) (45) (46) (47) (48) It is difficult to estimate the real incidence of cerebral vasospasm due to lack of a uniform definition, adequate diagnostic method and clear understanding of the pathophysiologic mechanism of spasm of cerebral arteries and changes in the microcirculation. Despite all these weaknesses, the clinical definition of cerebral vasospasm is one of the most commonly used. Nevertheless, clinical diagnosis of delayed cerebral ischemia is retrospective and is therefore not useful in clinical practice, where the main goal is to prevent this event. A series of biochemical markers of neuronal degradation products were tested and none of them proved to be a powerful marker of cerebral vasospasm and delayed cerebral ischemia. A palette of them combined is shown to be somewhat more reliable. Since all of them are markers of already developed neuronal damage, detection of mediators of vasoconstriction and ischemia that precede neuronal damage would be of significant interest to guide the treatment and to avoid cerebral damage.
In this study potential biomarkers for detection of cerebral ischemia such as: oxygen extraction and production of carbon dioxide and lactate in the brain tissue were tested together with endothelin-1, a peptide which probably plays a role in the development of cerebral vasospasm.
In this study there was no significant difference in endothelin-1 concentrations between the groups of patients operated due to ruptured and nonruptured cerebral aneurysm.
Venoarterial difference in endothelin-1 concentrations differed significantly on the day after the operation between groups of patients with a favorable and unfavorable neurologic outcome. Endothelin-1, analysed in samples before and during the operation of cerebral aneurysm, did not differ significantly between these two groups. When the population of patients, operated in the first 3 days after the aneurismal rupture, was analysed, there was a positive correlation of endothelin-1 levels found in the samples obtained at the time of induction of anesthesia and the time from rupture to operation.
These observations show that patients with a ruptured aneurysm and SAH experience a rise of endothelin-1 in the first several days, which corresponds to the usual delay for cerebral vasospasm to develop.
Interesting, is also the finding of a positive correlation between endothelin-1 concentrations before surgery and blood lactate in serial samples later. This indicates that endothelin-1 and lactate are both involved in the same pathophysiological process of delayed cerebral ischemia, which can determine the patient's outcome. The most logical explanation is that there is higher lactate production in ischemic brain tissue. Brain ischemia is provoked by vasospasm which could be mediated by endothelin-1, a potent vasoconstrictor. Still, other explanations are also possible.
A negative correlation between GCS before the operation and venoarterial difference in lactate concentration at the same time, suggests a higher lactate production in the brain of patients with a lower GCS. Positive correlation of endothelin-1 levels measured at the time of induction of anesthesia and the time period from rupture to operation was observed in the population of patients operated on in the first 3 days after the aneurismal rupture.
This was no longer present if all patients operated on after aneurismal rupture were included. Such an observation is in concordance with current knowledge about endothelin-1 concentrations rising in the first few days after rupture. (28, 49, 50) At the moment of awakening from general anesthesia, a lower pCO 2 in the jugular vein was found in the group of patients operated on after aneurismal rupture compared to the group operated on for a nonruptured cerebral aneurysm. A similar result was observed if the group of patients with supposed cerebral vasospasm and the group without it were compared, yet only with a borderline statistical significance. Also, lower pCO 2 was found both in arterial and venous blood in the group of patients operated on after aneurismal rupture in samples obtained at the moment of extubation and on the next day. There is also a clear correlation between lower postoperative GCS and lower pCO 2 in arterial and jugular vein blood after the operation. CO 2 is a product of aerobic metabolism, so lower pCO 2 production in ischemic tissue could be expected. But, other factors such as blood flow can theoretically also influence pCO 2 in venous blood. Lower arterial and consequently venous pCO 2 is best explained by spontaneous higher lung ventilation in these patients. The main question is whether this is a desirable compensatory mechanism or an impairment of optimal regulation. CO 2 is a well known cerebral vasodilator whereas hyperventilation leads to cerebral vasoconstriction. Therefore, hyperventilation can prevent development of brain edema, but can also worsen cerebral ischemia. A remaining question is whether mild hyperventilation resulting in lower pCO 2 could contribute to the development of cerebral vasospasm and delayed cerebral ischemia. This observation can bring up a question of changing the sedation protocol in patients with SAH to prevent spontaneous hyperventilation. In the case where this is a favorable compensatory mechanism, mild hyperventilation during general anesthesia could be an option. Further studies are needed to clarify these dilemmas.
The study is designed to identify potential biomarkers of cerebral ischemia, which could eventually be used in clinical practice. The number of patients enrolled in the study is big enough to detect a precise and reliable biomarker which is sensitive and specific enough to have significant predictive power. The majority of similar studies that tested biomarkers in patients with SAH had even smaller numbers of patients. The weakness of this study is that the observed patient population was not that severely ill as the other studied populations operated on for cerebral aneurysm with SAH. The lack of the most severe cases, with severe pathophysiologic derangement and unfavorable outcome, can hide potential differences between patients operated on electively and those operated on after aneurismal rupture. The same can be assumed for the potential difference between those with a favorable outcome, without any sequel, and those with some, but in general rather mild,neurologic impairment. In our study, the Hunt Hess score in the observed population of patients with a ruptured aneurysm was low, so a favorable outcome was GCS, Glasgow Coma Score; Hunt Hess, Hunt Hess score; P, statistical probability; pCO 2 , partial pressure of carbon dioxide; r S, Spearman's correlation coefficient. ** Correlation is significant at the 0.01 level * Correlation is significant at the 0.05 level Endothelin-1 in jugular vein 30 minutes after aneurismal clamping and arterial blood lactate on the day after the operation ,596 ,003
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